Q-Line Biotech Limited (NSE:QLINE)

India · Delayed Price · Currency is INR

531.40

-6.45 (-1.20%)

At close: Jul 20, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019
Manufacturing	2.30B	1.69B	700.54M	508.72M		-
Manufacturing Growth	36.25%	141.20%	37.71%	-		-
Trading	1.12B	1.45B	1.34B	1.32B		-
Trading Growth	-23.00%	8.40%	1.31%	-		-
Total	3.42B	3.14B	2.04B	1.83B		-
Total Growth	8.91%	54.08%	11.44%	-		-

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019
North India	2.53B	1.59B	1.42B		-
North India Growth	58.66%	11.89%	-		-
East India	248.75M	235.95M	194.79M		-
East India Growth	5.42%	21.13%	-		-
Central Zone	146.90M	94.64M	103.85M		-
Central Zone Growth	55.22%	-8.87%	-		-
South India	132.16M	59.46M	38.39M		-
South India Growth	122.26%	54.90%	-		-
West India	80.33M	51.97M	66.22M		-
West India Growth	54.57%	-21.52%	-		-
Export	3.51M	2.22M	1.15M		-
Export Growth	57.69%	93.90%	-		-
India	-	-	-		1.71B
India Growth	-	-	-		101.51%
Total	3.14B	2.04B	1.83B		1.71B
Total Growth	54.08%	11.44%	-		101.51%